ArticleMolecular biotechnology2025

DUSP1 Promotes Osimertinib Drug-Tolerant Persistence by Inhibiting MAPK/ERK Signaling in Non-small Cell Lung Cancer.

Wenjuan He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.